ArticleFrontiers in cellular and infection microbiology2022

CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy.

Stine Sofie Frank Lende et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.